Aurobindo gets FDA nod for nitrofurantoin oral suspension
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application nitrofurantoin oral suspension USP, 25 mg/5 mL.